• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • Samples
    • MRI Images
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

Interview with Sammy Danso

2019-01-24EPAD Academy, News

What is your current role in EPAD?

I am the resident Data Scientist based at the University of Edinburgh and I work closely with the International Coordinator for EPAD work package 4. The work package 4 includes the Longitudinal Cohort Study, which involves collecting and managing all the datasets that are collected from different sources in collaboration with EPAD industry partners such as IQVIA and Aridhia. I am responsible for providing the needed technical support to ensure high quality data is obtained. I am also a Fellow at the EPAD Academy.

What did you do prior to joining EPAD?

Prior to joining EPAD, I worked on several projects. I have over 18 years of experience developing systems to facilitate large-scale clinical and epidemiological studies whilst working for various research institutions including the London School of Hygiene and Tropical Medicine. The immediate past project I worked on prior to joining EPAD is the APPROACH (A Public-Private Research enabling Osteoarthritis Clinical Headway) project – when I joined Newcastle University in the United Kingdom as an Associate Researcher and led the data harmonisation activities of the project. Like EPAD, APPROACH is a cross-disciplinary and multi-centre involving study participants, researchers and professionals from academia and industry across Europe and also funded by the European Innovative Medicines Initiative.

Tell us a bit about the institution/company/organisation you work for.

The University of Edinburgh is a unique place to work as a Researcher and Data Scientist interested in applied Artificial Intelligence (AI) to dementia research. I am based at the Centre for Dementia Prevention, which is part of University of Edinburgh Medical School – one of the oldest and leading medical schools in the world. The University also has the biggest Informatics School in Europe where innovative data science and AI research are being carried out. The combined effect is that one gets the opportunity to meet and work with top professors and researchers in both fields – AI and medicine, specifically dementia.

What are your expectations from the EPAD project?

The current failure rate of clinical drug trails for Alzheimer’s disease is very alarming. This is partly due to the lack of suitable data available to carry out proof of concept trials. EPAD provides a unique opportunity to creating trial-ready cohorts using data driven approaches to facilitate biomarker discovery and clinical trials, which should hopefully lead to drug development and treatments of Alzheimer’s disease, which is currently a global burden.

Share this post
FacebookTwitterLinkedInGoogle+
Related posts
The final EPAD dataset is now available to the entire research community
2020-11-30
ALZFORUM
Alzforum conference blog mentions EPAD
2020-11-30
EPAD v1500 dataset
New webpage dedicated to EPAD data and samples on the EPAD website
2020-11-18
ADDI launches new Workbench to foster greater global research innovation and accelerate breakthroughs in Alzheimer’s disease and related dementias
2020-11-17
New paper investigating the prediction of Alzheimer’s disease biomarker status
2020-11-12
The Alzheimer’s Disease Data Initiative supports EPAD
2020-11-06
Latest Academy News
  • Two EPAD Fellows successfully defended their PhD thesis
    2020-04-20
  • David Hague Early Career Investigator of the Year Award 2020
    2019-06-07
  • 9th Call for the 2020 European Young Researchers’ Award is now open
    2019-05-23
  • Interview with Sammy Danso
    2019-01-24
  • Interview with the fellows: Lisa Vermunt and Delia Gheorghe
    2019-01-15
What’s new

The EPAD Academy programme for short-term exchanges is ready to go. EASP is a short-term exchange programme, interdisciplinary and rotational, between the EPAD Consortium Partners, established and supported by the EPAD Academy. Interested? Write to us at academy@ep-ad.org.

Open vacancies

Alzheimer Europe is looking to fill two Luxembourg-based positions! For more info check their website.

Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

We would like to thank all our followers! A massive thanks also goes to our research participants & members for all their support! Looking back on the years of the @IMI_EPAD project, here's key pictures took at major events. Have a safe & Happy New Year! youtu.be/FeYsOBOhCeo

reply retweet favorite
8:55 am · 2021-01-18
Twitter
EPAD
EPAD
@IMI_EPAD

The videos from #30AEC are online! Check out the @IMI_EPAD presentations on #data sharing by @rodrigobarnes (@aridhia) & Colin Veal (@uniofleicester). Thanks @IMI2_NEURONET and @AlzheimerEurope for giving us the opportunity to present our work. imi-neuronet.org/2020-virtual… twitter.com/IMI2_NEURONET/…

reply retweet favorite
8:43 am · 2021-01-15
Twitter
EPAD
EPAD
@IMI_EPAD

Authors investigated #data from nine studies, including @IMI_EPAD, comprising a total of 60,004 assessed participants. If you want to explore the #Alzheimer's disease data landscape, visit adata.scai.fraunhofer.de @BirkenbihlC @ApitiusHofmann @ddomingof @Simon_Lovestone @TVB_cloud

reply retweet favorite
7:56 am · 2021-01-11
Twitter
EPAD
EPAD
@IMI_EPAD

Numerous studies have collected #Alzheimer's disease cohort #data sets. @BirkenbihlC and colleagues have evaluated the Alzheimer's disease data landscape from a patient‐level data‐centric perspective. @IMI_EPAD @IMI_EMIF @NACCALZ alz-journals.onlinelibrary.wi…

reply retweet favorite
7:48 am · 2021-01-11
Twitter
EPAD
EPAD
@IMI_EPAD

The final @IMI_EPAD dataset is now available to the entire research community | News | @CORDIS_EU | European Commission europa.eu/!dj89jY

reply retweet favorite
12:55 pm · 2021-01-08
Copyright © 2015-19 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.